HOME > ARCHIVE
ARCHIVE
- PMDA Establishes Study Committee on Clinical Trials
September 5, 2005
- Current Gap Between NHI Prices and Market Prices 7-8%?
September 5, 2005
- NPA Recommends 0.36% Cut in Salary of National Gov't Employees
September 5, 2005
- Long-listed Drugs Should Be Reimbursed According to the Price of Their Generics: MOF
September 5, 2005
- OPINION
September 5, 2005
- Korosho Considers Reflecting Prices, Share of Generics in Prices of Long-listed Drugs
September 5, 2005
- Korosho, Monkasho to Draft New Plan to Promote Clinical Trials
September 5, 2005
- Japan Needs Review System That Meets Its Own Needs: Mr Asonuma
September 5, 2005
- SELF-MEDICATION NEWS IN BRIEF
September 5, 2005
- SURVEY 3 articles
September 5, 2005
- Tonic Drinks: Sales of New Quasi-drugs Outpace OTC Products
September 5, 2005
- Uncollected Medical Fees - Why Don't Patients Pay?
September 5, 2005
- HUMAN RESOURCE NEWS IN BRIEF
September 5, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 5, 2005
- 1st Qtr Business Results
September 5, 2005
- JMACCT to Determine Number of Patients Seen by Each Institution by Disease
September 5, 2005
- BUSINESS NEWS IN BRIEF
September 5, 2005
- New Regenerative Therapy Using Cell Sheets Reported: Dr Okano
September 5, 2005
- FDGscan May Dramatically Change Cancer Diagnosis in Japan
August 29, 2005
- Ono Announces Results of PII Study of Cereact for ALS
August 29, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
